| Financial Year |
March 31 2023 |
| Monetary Funds |
37,127,535,519.91 |
| Held-for-trading Financial Assets |
64,304,073,409.84 |
| Notes Receivable |
-- |
| Accounts Receivable |
61,026,219.97 |
| Advances to Suppliers |
202,891,944.74 |
| Other Receivables |
670,228,770.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
30,258,923.28 |
| Dividend Receivable |
47,645,279.88 |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
188,963,786,188.99 |
| Other Current Assets |
47,803,207,443.46 |
| Total Current Assets |
644,667,426,827.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
41,413,582,134.32 |
| Long-term Equity Investment |
15,101,219,532.35 |
| Investment Properties |
127,786,360.36 |
| Fixed Assetes |
9,132,401,233.87 |
| Under-construction Projects |
56,101,511.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
589,962,168.75 |
| R&D expenses |
-- |
| Goodwill |
27,305,112.94 |
| Long-Term Deferred and Prepaid Expenses |
72,014,804.85 |
| Deferred Income Tax Assets |
3,955,231,415.69 |
| Other Non-Current Assets |
418,100,945.85 |
| Sub-Total of Non-Current Assets |
360,581,233,677.08 |
| Total Assets |
1,005,248,660,504.83 |
| Short-Term Loans |
30,215,595,249.31 |
| Trading Financial liabilities |
1,669,909,723.66 |
| Notes Payable |
240,536,692.08 |
| Accounts Payable |
42,331,711.87 |
| Accounts Received In Advance |
964,269,262.44 |
| Employee Compensation Payable |
147,500,364.84 |
| Taxes Payable |
935,277,941.05 |
| Interest Payable |
-- |
| Dividend Payable |
32,228.53 |
| Other payables |
2,207,583,007.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,406,908,119.84 |
| Other Current Liabilities |
40,301,638,342.25 |
| Sub-Total of Current Liabilities |
805,903,199,459.06 |
| Long-term Loans |
7,261,052,745.66 |
| Bonds Payable |
4,387,725,076.58 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
601,569,026.82 |
| Deferred Income Tax Liabilities |
360,519,179.64 |
| Other Non-Current Liabilities |
1,283,320,108.91 |
| Sub-Total of Non-Current Liabilities |
19,842,518,610.78 |
| Total Liabilities |
825,745,718,069.84 |
| Paid-In Capital(Or Share Stock) |
12,642,079,079.00 |
| Capital Surplus |
35,047,817,540.99 |
| Surplus Reserve |
6,982,883,707.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
35,399,055,873.38 |
| Minority Stockholder's Interest |
81,578,644,354.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
97,924,298,080.13 |
| Owner's Equity（Stockholder's Equity） |
179,502,942,434.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,005,248,660,504.83 |
